Radiation Oncology/Therapy: Page 58

FDA commissioner Hahn leaves agency
By Brian Casey
Dr. Stephen Hahn, the commissioner of the U.S. Food and Drug Administration (FDA), has left the agency. He is being replaced on an interim basis by longtime FDA regulator Dr. Janet Woodcock.
January 19, 2021
2019 11 01 22 16 2253 Hahn Stephen 20191101221734
Lantheus submits drug master file for imaging biomarker
By AuntMinnie.com staff writers
Lantheus Holdings, parent company of Lantheus Medical Imaging, said that it has filed a drug master file with the U.S. Food and Drug Administration for NM-01, a PD-L1 imaging biomarker for use in nuclear medicine.
January 11, 2021
2021 01 12 22 13 6193 Immunotherapy T Cell Fluorescence 400
Sun Nuclear's SunCheck nets more than 1,000 global users
By AuntMinnie.com staff writers
Radiation oncology quality-assurance technology developer Sun Nuclear has announced that its SunCheck quality management platform has netted more than 1,000 users in almost 60 countries.
January 10, 2021
2021 01 11 21 32 7508 Sun Astro 2019 400
ImaginAb, Pfizer ink deal on PET agent
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb signed a multiyear, nonexclusive license with Pfizer to supply the zirconium-89 CD8 Immuno-PET agent, which can be used to image CD8 T cells in cancer patients.
January 7, 2021
2020 09 01 17 32 7659 Business Woman Handshake 400
RefleXion partners with HealthMyne on cancer radiomics
By AuntMinnie.com staff writers
Radiation therapy developer RefleXion Medical has signed a deal with HealthMyne to combine technologies to apply oncology radiomics to radiation therapy treatments.
January 7, 2021
2020 03 12 17 01 2761 Reflexion Astro 2019 400
Avacta inks license agreement with Point Biopharma
By AuntMinnie.com staff writers
Avacta Group has signed a license agreement with Point Biopharma to provide that company with access to its pre/Cision technology for developing tumor-activated radiopharmaceuticals.
January 6, 2021
2016 08 24 09 43 13 537 Hands Shaking V3 400
ViewRay prepares for $50M stock offering
By AuntMinnie.com staff writers
Image-guided radiation therapy vendor ViewRay expects to raise approximately $50 million in gross proceeds from a public offering of its common stock this week.
January 4, 2021
2019 09 17 17 11 0207 Viewray Astro 2019
Accuray nets FDA nod for ClearRT imaging technology
By AuntMinnie.com staff writers
Radiation oncology firm Accuray has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its ClearRT helical kilovoltage CT imaging technology.
January 4, 2021
2019 09 17 16 01 9179 Accuray Astro 2019
ViewRay posts mixed financial results for Q4, year
By AuntMinnie.com staff writers
Image-guided radiation therapy vendor ViewRay reported a sharp decline in revenues for its fiscal year 2020 compared with the year before, but it was able to reverse the trend in the fourth quarter.
January 3, 2021
2019 09 17 17 11 0207 Viewray Astro 2019
Report: COVID-19 causing radioisotope delays
By AuntMinnie.com staff writers
A drop in the volume of passenger airline travel is causing delays in the shipment of medical radioisotopes from sources in Canada, according to a January 3 report by Reuters.
January 3, 2021
2020 04 21 21 57 4715 Airplane Takeoff2 400
ASTRO lauds delay of radiation therapy payment reform
By Brian Casey
The American Society for Radiation Oncology (ASTRO) is lauding a provision included in the massive U.S. government spending bill passed December 21 that would push to January 2022 implementation of payment reform for radiation therapy procedures.
December 21, 2020
2018 10 21 20 23 4419 Astro 20181022040021
South Korean hospital hits milestone with ViewRay system
By AuntMinnie.com staff writers
The Seoul National University Hospital in South Korea announced that it has hit a milestone with its MRIdian MRI-guided radiation therapy system from ViewRay, having treated 1,000 patients in the last five years.
December 21, 2020
2019 09 17 17 11 0207 Viewray Astro 2019
Previous Page
Page 58 of 465
Next Page